Brian DeSchuytner
2022
Compensation breakdown
| Non-Equity Incentive Plan | $198,012 |
|---|---|
| Option Awards | $514,170 |
| Salary | $421,303 |
| Stock Awards | $157,000 |
| Other | $7,000 |
| Total | $1,297,485 |
DeSchuytner received $514.2K in option awards, accounting for 40% of the total pay in 2022.
DeSchuytner also received $198K in non-equity incentive plan, $421.3K in salary, $157K in stock awards and $7K in other compensation.
Rankings
In 2022, Brian DeSchuytner's compensation ranked 2,529th out of 5,760 executives tracked by ExecPay. In other words, DeSchuytner earned more than 56.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,529 out of 5,760 | 56th |
Division Manufacturing | 1,393 out of 3,136 | 56th |
Major group Chemicals And Allied Products | 631 out of 1,422 | 56th |
Industry group Drugs | 585 out of 1,323 | 56th |
Industry Pharmaceutical Preparations | 419 out of 969 | 57th |
Pay ratio
| Brian DeSchuytner's Pay | $1,297,485 |
|---|---|
| Median Employee's Pay | $243,051 |
| Pay Ratio | 5to 1 |
In 2022, the annual total compensation of Brian DeSchuytner was $1,297,485.
The annual total compensation of the median employee at Mersana Therapeutics was $243,051.
The ratio of Brian DeSchuytner's pay to the pay of median employee was therefore 5 to one.
DeSchuytner's colleagues
We found four more compensation records of executives who worked with Brian DeSchuytner at Mersana Therapeutics in 2022.
News
April 26, 2024
April 28, 2023
April 29, 2022
April 27, 2021
April 20, 2020